Health May Be Adversely Affected By The Wait For Biopsy Results Women who've had a breast biopsy know the anxiety of waiting for the results, but that stress may cause adverse health effects, according to a new study published in the March issue of Radiology. "When women express how taxing it is to have to wait for results, the medical establishment may dismiss their feelings as psychological," said the study's lead author, Elvira V. Lang, M.D.
Source: www.medicalnewstoday.comInfoMedics Survey Clearly Demonstrates Gap Between Doctors' Orders And Patient Prescription Behaviors InfoMedics, Inc., the patient feedback company, announced the results of a survey examining the behaviors of patients on
prescription medications. The findings show that a significant portion of medication users tend to ignore or stray from their doctor's orders, and that there are opportunities for improved patient-physician communication.
Source: www.medicalnewstoday.comLong-Term Survival In Premenopausal Women With Early Breast Cancer Improved By Goserelin Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, according to trial data reported in the February 24 online issue of the Journal of the National Cancer Institute.
Source: www.medicalnewstoday.comSimulation Gives Employers the Edge in Hiring Top Talent Key HR trends for 2009 include the expanding use of employment simulations for hiring, developing, and retaining high-performing employees. (PRWeb Feb 25, 2009)
Read the full story at http://www.prweb.com/releases/2009/02/prweb2179414.htm
Source: www.prweb.comHonored for EMR Sophistication, HIMSS Analytics Announces Stage 6 Hospitals Only 42 out of the more than 5,000 US hospitals tracked by HIMSS Analytics has achieved this recognition for implementation of the electronic medical record (PRWeb Feb 26, 2009)
Read the full story at http://www.prweb.com/releases/Stage_6_Hospitals/Healthcare_IT/prweb2190304.htm
Source: www.prweb.comSorin Group Announces Start Of Patient Enrolment In 'Perceval S' Sutureless Aortic Valve Clinical Trial In Europe Sorin Group, (MIL:SRN), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the enrolment of the first three patients in a clinical trial aimed at obtaining European market approval for its 'Perceval S' Sutureless Aortic Heart Valve. In a previous pilot study (First-In-Man), 30 patients at high surgical risk were enrolled in three European centres.
Source: www.medicalnewstoday.comPredicting Risk Of Stroke From One's Genetic Blueprint A new statistical model could be used to predict an individual's lifetime risk of stroke, finds a study from the Children's Hospital Informatics Program (CHIP). Using genetic information from 569 hospital patients, the researchers showed that their predictive model could estimate an individual's overall risk of cardioembolic stroke -- the most common form of stroke -- with 86 percent accuracy. The findings are reported in the March issue of Stroke.
Source: www.medicalnewstoday.comPoniard Pharmaceuticals Announces New Efficacy And Safety Data From A Phase 2 Picoplatin Trial In Patients With Prostate Cancer Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of new efficacy and safety data from its ongoing Phase 2 clinical trial of picoplatin in combination with docetaxel and prednisone as first-line therapy for metastatic castration-resistant prostate cancer (CRPC).
Source: www.medicalnewstoday.com
# posted by Network @ 4:01 PM
